Agreed. Waiting for deals on Asthma, CLI and Diabetic Ulcers as...

Agreed. Waiting for deals on Asthma, CLI and Diabetic Ulcers as these are ready for partnering.
What's a partnering deal worth on each of these indications??

As per the companies last presentation:
"Valuable market opportunity: Estimated US$1.7bn revenue opportunity for MSC supplier for GvHD and CLI products alone"

Just for comparison below on market size.


GvHD
$USD 300m market size
$3m upfront (Fuji deal) alone
$60+m milestones
$30m p.a. royalties


CLI
$USD 1.4b market size (4.6x GvHD)
therefore approx
~$14m upfront
~$276+m milestones
~$138m p.a. royalties

Interesting times ahead